(1)
Bimekizumab Speed of Response in Patients With Moderate to Severe Plaque Psoriasis: Results from Four Phase 3 3b Trials (BE VIVID, BE READY, BE SURE, and BE RADIANT). J of Skin 2022, 6 (6), s69. https://doi.org/10.25251/skin.6.supp.69.